| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.0069 | 1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.0063 | 1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |